Jiménez de Oya, N.; Pérez, P.; Blázquez, A.-B.; Escribano-Romero, E.; Esteban, M.; Saiz, J.-C.; GarcÃa-Arriaza, J.; MartÃn-Acebes, M.A.
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara. Pharmaceuticals 2022, 15, 354.
https://doi.org/10.3390/ph15030354
AMA Style
Jiménez de Oya N, Pérez P, Blázquez A-B, Escribano-Romero E, Esteban M, Saiz J-C, GarcÃa-Arriaza J, MartÃn-Acebes MA.
Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara. Pharmaceuticals. 2022; 15(3):354.
https://doi.org/10.3390/ph15030354
Chicago/Turabian Style
Jiménez de Oya, Nereida, Patricia Pérez, Ana-Belén Blázquez, Estela Escribano-Romero, Mariano Esteban, Juan-Carlos Saiz, Juan GarcÃa-Arriaza, and Miguel A. MartÃn-Acebes.
2022. "Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara" Pharmaceuticals 15, no. 3: 354.
https://doi.org/10.3390/ph15030354
APA Style
Jiménez de Oya, N., Pérez, P., Blázquez, A.-B., Escribano-Romero, E., Esteban, M., Saiz, J.-C., GarcÃa-Arriaza, J., & MartÃn-Acebes, M. A.
(2022). Low Immune Cross-Reactivity between West Nile Virus and a Zika Virus Vaccine Based on Modified Vaccinia Virus Ankara. Pharmaceuticals, 15(3), 354.
https://doi.org/10.3390/ph15030354